A population of catalytic RNA molecules has been engineered to operate and evolve in vitro in a continuous manner. The novel continuity of the process allows the propagation of many generations in a very short time and without the manual manipulation necessary with traditional in vitro selection techniques. Thirty years ago, Sol Spiegelman and his colleagues [1] developed a system for observing molecular evolution in a test-tube. The bacteriophage Q␤ has a single-stranded RNA genome that encodes a polymerase, Q␤ replicase, which, as its name implies, can copy and ultimately regenerate the Q␤ genome. When Q␤ replicase is added to Q␤ RNA in vitro, shorter RNA 'midi-variants' accumulate. The midi-variants can be efficiently replicated, and accumulate mutations and deletions that further increase their rate of replication. This model of test-tube evolution is extremely adaptable, and it was manipulated to generate RNA molecules that could be replicated in the presence of ethidium bromide [2] , or that could move through capillary tubes based on their rates of replication [3] .
Wright and Joyce [4] have now succeeded Spiegelman by developing a system for observing molecular evolution in which the template and at least part of the copying function are combined in one molecule (Fig. 1) . These authors started with a powerful ligase ribozyme selected by Bartel and Szostak [5] , and optimized in Bartel's laboratory [6] . The ligase base-pairs with an RNA substrate, and catalyzes the formation of a 3′-5′ phosphodiester bond by displacing a pyrophosphate from its 5′ triphosphate terminus. The ligation product can be exponentially amplified by a combination of reverse transcription and in vitro transcription (the so-called isothermal amplification reaction [7] ). The identity of the base-pairing interactions between the ribozyme and its substrate can be altered at will, and Wright and Joyce [4] mutated four nucleotides in the template region of the ribozyme, so that the resultant ligation junction would resemble the promoter for T7 RNA polymerase.
The ligation substrate used by Wright and Joyce [4] was actually a DNA-RNA hybrid -a short 5′ DNA strand that terminates in four ribonucleotides. Ligation followed by reverse transcription therefore generates a nucleic acid duplex consisting of a DNA-RNA hybrid and a complementary DNA strand (Fig. 1) . A new T7 RNA polymerase promoter is formed near the DNA-RNA junction. The start site for transcription lies just past the ligation junction,
Figure 1
The continuous evolution scheme of Wright and Joyce [4] . RNA molecules catalyze selfligation to form a short DNA-RNA hybrid (RNA is red and DNA blue). A primer binds to the 3′ end of the hybrid and it is reverse transcribed in the same reaction mix. The double-stranded nucleic acid contains a T7 RNA polymerase promoter. Subsequent transcription by T7 RNA polymerase generates multiple copies of the original RNA molecule, which can then repeat the ligation and amplification cycle. Mutations can accumulate during this process, and more fit variants of the original ribozyme can be preferentially amplified and should eventually displace ancestral sequences from the population. and RNA molecules that correspond to the sequence of a catalytically active ligase can therefore be transcribed from the reverse transcription product. The significance of this scheme, compared to other schemes for in vitro selection, is that it can occur continuously. Previous in vitro selections generally separated the selection and amplification steps; for example, in the ligase selection originally carried out by Bartel and Szostak [5] full-length products were captured on an affinity column, reverse transcribed, amplified by the polymerase chain reaction (PCR) and transcribed in vitro. In Wright and Joyce's continuous evolution scheme [4] , ligation products directly regenerate double-stranded nucleic acid templates, new RNAs are synthesized from these templates, these RNAs can in turn participate in new ligation reactions, and so forth.
The success of the continuous evolution scheme was highly dependent on two factors. First, the use of the isothermal amplification procedure, rather than a combination of other copying and amplification reactions, meant that replication could take place in the same tube in which the ligation reaction occurred. More importantly, though, the use of Bartel's ligase was essential. Previous selections for ligation activity had been carried out using a group II intron ribozyme and isothermal amplification, yet these did not yield a continuous evolution scheme [8] . The speed of the natural ribozyme was slow relative to the speed of the amplification reaction, so slow, in fact, that most ribozymes may have been converted into double-stranded (and hence inactive) molecules before they could catalyze primer addition. Similarly, the relatively slow and inefficient amplification of the natural ribozyme abetted the evolution of an interesting parasite, 'RNA Z', which could more efficiently feed off of the isothermal amplification scheme [8] .
The variant of Bartel's ligase that Wright and Joyce [4] generated by mutagenesis of the ribozyme's template region was a factor of 10 000 slower than its parent, and was also originally too slow to participate in the continuous evolution scheme. Therefore, a population of sequence variants centered on the ribozyme was generated, and more efficient ligators were identified following 15 rounds of 'conventional' selection. Although the resultant population was ~100-fold more active than the parental ribozyme, variants in this population were still not active enough to undergo continuous evolution. Ligator activity was further increased by carrying out 100 cycles of a simplified selection protocol, in which ribozymes were allowed to react for five minutes and were then transferred to the amplification reaction mixture.
The ribozyme population generated by this 'manual' evolution was finally adequate to 'kick start' continuous evolution. The initial reaction was seeded with 10 11 copies of the evolved ligase. After 60 minutes a portion of the reaction mixture (about 10 10 molecules, containing templates and ribozymes) was transferred to a new 'food' source -a fresh tube of substrate, primers, enzymes and nucleoside triphosphates. The ribozymes multiplied, reproducing roughly 1000 copies of every individual. As is the case with natural selection, new variants arose during the amplification procedure, and could compete for the available 'food'.
Over the course of many cycles of continuous evolution, only the fastest or the most fecund ribozymes survived. In fact, after 100 cycles many of the catalytic properties of the selected ribozyme population had markedly improved. The catalytic efficiency of at least one member of the population had improved 10 000-fold (Fig. 2) , and its exponential growth rate had improved by over nine orders of magnitude! The continuously evolved ligase was found to be much faster than Bartel and Szostak's original ribozyme [5] , and even faster than Bartel's optimized ligase (with a turnover of 20 per minute, compared to 14 per minute, albeit under slightly different reaction conditions).
Perhaps the most notable accomplishment of the continuous evolution experiment is that the successful ligases were Figure 2 A comparison of the activities of evolved ribozymes. The relative rates (k cat ) of ribozyme ligases isolated by different procedures are shown on a log scale. The ribozymes listed include: b1, the original class I ribozyme isolated from a 220 residue random sequence population by Bartel and Szostak [5] ; b1-207, the optimized class I ribozyme isolated from a doped sequence pool by Ekland et al. [6] ; T7 mut, the variant in which the base-pairing interactions of the optimized class I ribozyme have been altered (Wright and Joyce's starting point); 15 rnds, descendants of T7 mut after 15 rounds of conventional selection; 100 rnds, descendants after 100 rounds of a quick selection protocol; and Con evol, descendants after 100 serial transfers of continuous evolution [4] . This graph is primarily meant to give a qualitative idea of the degree of rate enhancement afforded by different procedures; the numbers used in the construction of this graph were determined using different reaction conditions and therefore are not quantitatively comparable. ) generated in only 52 hours, the results of 300 cycles of catalysis with an overall amplification factor of 10 298 . Given that the amplification factor of organisms such as bacteria or humans is roughly two per generation, the ribozymes have had the same opportunities to replicate and conquer in their environment as, say, bacteria reproducing for 500 hours or humans reproducing for the past 20 000 years. Despite the accelerated time frame of the in vitro evolution experiment, it is clear that the ribozymes have evolved in much the same way as their bacterial or human counterparts -by the accumulation of point mutations. For example, a ribozyme isolated before the initiation of continuous evolution had already accumulated 17 point mutations, while a ribozyme isolated following continuous evolution had accumulated 29 point mutations. Although some of the mutations may have been 'neutral' and could have resulted from serial population bottlenecks, others were shown to alter substrate binding and/or replication efficiency.
These experiments may herald a quantum leap in our ability to manipulate nucleic acids by in vitro evolution. For example, the continuous evolution procedure can now serve as a wonderful tool for exploring the population biology and evolutionary mechanisms of ribozymes. Generation upon generation of molecules can be selected with ease, their sequences analyzed, and their march through sequence and function landscapes plotted. New ribozyme activities can be evolved more readily. Wright and Joyce [5] point out that, as Ekland and Bartel [6] have shown that the ribozyme ligase can also catalyze the template-directed polymerization of a limited number of nucleoside triphosphates, the continuous evolution scheme might be adapted to a short gap-filling reaction. Should this experiment prove successful, an outcome which can apparently be known in days rather than months, then it would be possible to attempt selection for ribozymes with polymerase activity capable of filling longer gaps or gaps in trans.
The apparent ease of the new procedure encourages completely new experiments, such as continuous evolution experiments in which successful species use cofactors present in the reaction mixture. For example, aminoglycoside antibiotics are known to bind readily to nucleic acids and contain nucleophiles not found in RNA. A continuously evolving ribozyme could potentially generate an appropriately-placed aminoglycoside-binding site and thereby augment its own catalytic activity. The resultant aminoglycoside-dependent ribozyme could then be used as a means of detecting aminoglycosides in solution. Continuous evolution can therefore potentially be used as a general method for the facile evolution of ribozyme diagnostics.
One of the most profound implications of the continuous evolution experiments is how they beg an adequate definition of life. Scientists and philosophers sometimes consider bacteria to be living and bacteriophage to be inert. The partition between non-living and living systems can be predicated on the nature of the environment for replication -a bag of enzymes versus a less complex broth -but this distinction rings hollow given that both replicators are equally stymied by a lack of an essential nutrient, be it DNA polymerase or glucose. The distinction can also be founded on the notion that living systems are somehow more continuous than non-living ones, constantly dividing and adapting to their environment. However, the fact that bacteriophages are idling machines that can wait on a new bag of enzymes seems no different in principle than the fact that spores are idling machines that can wait on a liquid, nurturing environment.
The ability to mutate and adapt can be cited as the rubicon that living systems must cross. Again, though, bacteriophage and cells contain similar genetic material and can mutate and be selected in much the same way. Thus, from our perspective there is no reason to call a cell alive and a bacteriophage inert. If so, there is really no reason to call a ribozyme ligase inert: given a suitable tube of enzymes and substrates, the ligase can replicate, mutate, and adapt. Of course, based on these suppositions and definitions, Sol Spiegelman's midi-variants and any molecule in an in vitro selection experiment are similarly 'alive'.
In the end, we believe that discussions about the definition of 'life' serve merely to bring into sharp focus the pressing need to relegate this term to poetry rather than biology. It must be admitted, however, there is something more viscerally appealing about a continuously evolving ligase than a ribozyme whose activity has been painstakingly teased out of a random sequence population. While in vitro selection procedures provide a molecular complement to the naturalistic observations initiated by biology's intellectual forebear, Charles Darwin, the incredible speed and ruthless efficiency of the continuous evolution procedure speaks to the spirit of his contemporary, Alfred Lord Tennyson who, in an unknown appeal to the vicissitudes of research, wrote:
"Man, her last work, who seem'd so fair, Such splendid purpose in his eyes, Who roll'd the psalm to wintry skies, Who built him fanes of fruitless prayer, Who trusted God was love indeed And love Creation's final law --Tho' Nature, red in tooth and claw With ravine, shriek'd against his creed"
